Journal
CLINICAL OBSTETRICS AND GYNECOLOGY
Volume 52, Issue 3, Pages 456-468Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/GRF.0b013e3181b5a57c
Keywords
postpartum depression; identification; screening tools
Categories
Funding
- National Institute of Mental Health [R01 MH60335, K23 MH082114-01 A2, R01 MH071825, R01 MH075921]
- International Society of Bipolar Disorders Fellowship Award
- Society for Bariatric Surgery
- Heinz Foundation
- New York-Mid-Atlantic Consortium for Genetics and Newborn Screening Services
- Novogyne
- Pfizer
- Stanley Medical Research Foundation
- State of Pennsylvania
- NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071825, R01MH060335, K23MH082114, R01MH075921] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Postpartum depression (PPD) is the most common medical complication of childbearing. Universal screening maximizes the likelihood of prompt identification of PPD. Obstetrician-gynecologists routinely evaluate postpartum women for a general health examination and review of family planning options at approximately 6 weeks after birth; therefore, they are well positioned to identify PPD. In this study, we review the diagnostic criteria for postpartum depressive disorders and clinical risk factors predictive of PPD. We examine depression screening tools, appropriate cut-points associated with positive screens, the optimal timing for screening, and the acceptability of depression screening in obstetrical settings. Finally, we explore how to manage patients who screen positive for depression and treatment options for women with PPD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available